Huntington’s Disease Epidemiology Forecast to 2030

 Breaking News
  • No posts were found

Huntington’s Disease Epidemiology Forecast to 2030

April 01
13:28 2020
Huntington\'s Disease Epidemiology Forecast to 2030

 

DelveInsight has launched a new report on Huntington’s Disease Epidemiology and Market Forecast-2030

DelveInsight’s ‘Huntington’s Disease – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Huntington’s Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

According to Huntington’s Disease Society of America, Huntington’s disease is a fatal genetic disorder that causes the progressive breakdown of nerve cells in the brain. It deteriorates a person’s physical and mental abilities usually during their prime working years and has no cure.Huntington’s disease is a hereditary neurodegenerative disorder caused by mutation in the HTT genes. The HTT mutation that causes Huntington disease involves a DNA segment known as a CAG trinucleotide repeat. This segment is made up of a series of three DNA building blocks (cytosine, adenine, and guanine) that appear multiple times in a row.

 

Request for : Huntington’s Disease Epidemiology free sample page

Epidemiology

The Huntington’s Disease epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Huntington’s Disease epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Huntington’s Disease epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Epidemiology Segmentation

The Huntington’s Disease epidemiology covered in the report provides historical as well as forecasted Huntington’s Disease epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.

The DelveInsight Huntington’s Disease report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Major key companies are working on Huntington Disease are given below :-

1. Roche Pharma Co. 
2. EIP  Pharma Co. 
 
Name of drugs covered are given below:-
1. RG6042 (RO7234292
2. Neflamapimod

Table of contents

1. Key Insights 

2. Executive Summary of Huntington’s Disease

3. Huntington’s Disease: Disease Background and Overview

3.1. Introduction

3.2. Sign and Symptoms

3.3. Pathophysiology

3.4. Risk Factors

3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

6. Treatment Algorithm, Current Treatment, and Medical Practices

6.1. Huntington’s Disease Treatment and Management

6.2. Huntington’s Disease Treatment Algorithm

7. KOL Views

8. Unmet Needs

9.  Appendix

9.1. Bibliography

9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

Why should you buy this report?

  • The Huntington’s Disease Epidemiology report will allow the user to –
  • Develop business strategies by understanding the trends shaping and driving the global Huntington’s Disease market
  • Quantify patient populations in the global Huntington’s Disease market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Huntington’s Disease therapeutics in each of the markets covered
  • Understand the magnitude of Huntington’s Disease population by its epidemiology
  • The Huntington’s Disease Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Related Reports:-

1. Huntington’s Disease- Market Insight, Epidemiology and Market Forecast -2030

2. Huntington’s Disease- Pipeline Insights, 2020

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

Categories